United Pharm Working Capital to Net Assets Ratio
United Pharm working capital to net assets ratio. United Pharm (033270) has a Working Capital to Net Assets ratio of 49.4% as of June 2026. Working capital of ₩245.72 Billion (current assets of ₩300.07 Billion minus current liabilities of ₩54.35 Billion) is measured against net assets of ₩497.12 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of United Pharm (2011–2025)
Working capital to net assets ratio of United Pharm from 2011 to 2025. This chart shows how United Pharm's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 49.4%, reflecting working capital of ₩245.72 Billion against net assets of ₩497.12 Billion KRW. Explore investment intensity of United Pharm to see how much of total assets are deployed in long-term investments.
United Pharm Working Capital to Net Assets Ratio by Year (2011–2025)
United Pharm working capital to net assets ratio by year from 2011 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for United Pharm from 2011 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 033270 asset base.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 48.6% | ₩220.93 Billion | ₩454.63 Billion | ₩268.68 Billion | ₩47.75 Billion | ▲ +0.2 pp |
| 2024 | 48.4% | ₩196.56 Billion | ₩406.21 Billion | ₩244.75 Billion | ₩48.19 Billion | ▲ +2.9 pp |
| 2023 | 45.5% | ₩172.14 Billion | ₩378.68 Billion | ₩244.73 Billion | ₩72.59 Billion | ▼ -1.5 pp |
| 2022 | 46.9% | ₩158.51 Billion | ₩337.86 Billion | ₩224.39 Billion | ₩65.88 Billion | ▼ -0.8 pp |
| 2021 | 47.7% | ₩143.50 Billion | ₩300.71 Billion | ₩204.36 Billion | ₩60.85 Billion | ▲ +4.0 pp |
| 2020 | 43.7% | ₩121.13 Billion | ₩276.89 Billion | ₩180.92 Billion | ₩59.79 Billion | ▲ +2.3 pp |
| 2019 | 41.5% | ₩105.82 Billion | ₩255.10 Billion | ₩164.52 Billion | ₩58.70 Billion | ▲ +1.0 pp |
| 2018 | 40.4% | ₩92.38 Billion | ₩228.48 Billion | ₩152.45 Billion | ₩60.07 Billion | ▲ +1.9 pp |
| 2017 | 38.5% | ₩77.66 Billion | ₩201.68 Billion | ₩127.82 Billion | ₩50.16 Billion | ▼ -4.2 pp |
| 2016 | 42.7% | ₩75.75 Billion | ₩177.39 Billion | ₩115.39 Billion | ₩39.64 Billion | ▼ -8.6 pp |
| 2014 | 51.3% | ₩83.00 Billion | ₩161.83 Billion | ₩111.43 Billion | ₩28.43 Billion | ▲ +4.5 pp |
| 2013 | 46.8% | ₩66.17 Billion | ₩141.44 Billion | ₩92.83 Billion | ₩26.66 Billion | ▲ +2.9 pp |
| 2012 | 43.9% | ₩58.60 Billion | ₩133.48 Billion | ₩93.18 Billion | ₩34.58 Billion | ▲ +0.1 pp |
| 2011 | 43.8% | ₩49.51 Billion | ₩113.04 Billion | ₩87.95 Billion | ₩38.44 Billion | — |